Bayard D. Clarkson

Crystal structures of the kinase domain of c-Abl in complex with the small molecule inhibitors PD173955 and imatinib (STI-571).

Bhushan Nagar, William G. Bornmann, Patricia Pellicena et al. · PubMed · 2002 · 941 citations

Life Sciences, Medicinal Chemistry, Molecular Biology +13

On the Use of Cause-Specific Failure and Conditional Failure Probabilities: Examples from Clinical Oncology Data

Jeffrey J. Gaynor, Eric J. Feuer, Claire C. Tan et al. · Journal of the American Statistical Association · 1993 · 480 citations

Public Health, Biostatistics, Oncology +17

p62 : A Constitutively Tyrosine-Phosphorylated, GAP-Associated Protein in Chronic Myelogenous Leukemia Progenitor Cells

Nick Carpino, David Wisniewski, A Strife et al. · Cell · 1997 · 369 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +15

Toxicity of E. coli L-asparaginase in man

Herbert F. Oettgen, Phyllis A. Stephenson, Morton K. Schwartz et al. · Cancer · 1970 · 287 citations · Full text

Pharmacy, Clinical Toxicology, Toxicology +13

L576P KIT mutation in anal melanomas correlates with KIT protein expression and is sensitive to specific kinase inhibition

Cristina R. Antonescu, Klaus J. Busam, Todd D. Francone et al. · International Journal of Cancer · 2007 · 242 citations · Full text

Medicine, Dermatology, Oncology +17